Dual roles of Nell-1 in craniofacial bones and brain through interaction with Cntnap4
Nell-1 通过与 Cntnap4 相互作用在颅面骨和大脑中发挥双重作用
基本信息
- 批准号:10674475
- 负责人:
- 金额:$ 47.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAgonistBehaviorBehavior assessmentBehavioralBindingBone GrowthBone RegenerationBrainBreedingCalvariaCell surfaceCellsCephalicCraniosynostosisDataDefectDevelopmentDrug or chemical Tissue DistributionEmbryoEthylnitrosoureaEventExhibitsFiberFrontal bone structureGABA AgonistsGoalsGrowth and Development functionHistologyHumanIntegrinsInterneuronsInterventionKnock-outKnockout MiceKnowledgeLigandsLinkLoxP-flanked alleleMeasurementMediatingMembraneMembrane ProteinsMolecularMorphologyMusMutant Strains MiceNatural regenerationNeonatalNervous SystemNeural Crest CellNeuronsOsteoblastsOsteogenesisOutcomeOutputParietal bone structureParvalbuminsPathogenesisPatientsPhosphorylationProcessPropertyProteinsRoleSensory GangliaSignal TransductionSkeletal DevelopmentSkeletal systemSpecific qualifier valueStructure of trigeminal ganglionSynaptic TransmissionTestingTherapeuticTissuesTransgenic OrganismsTranslatingWNT Signaling PathwayWild Type Mouseautism spectrum disorderbeta cateninbonebone healingbone repairbrain tissuecomparativecraniofacialcraniofacial bonegamma-Aminobutyric Acidglycogen synthase kinase 3 betahealingimprovedinhibitormembermicroCTneuralneurological pathologynovelnovel therapeuticsosteogenicosteogenic proteinoverexpressionpostnatalprematurepresynapticreceptorrepairedskeletalskeletal tissuespatiotemporalsuture fusiontransmission process
项目摘要
PROJECT SUMMARY
Nell-1 has been studied extensively for its osteogenic role in craniofacial skeletal development. However, despite
its high expression in the brain, there has been a lack of understanding of Nell-1's function in the nervous system
until the recent identification of a ligand-receptor like interaction between Nell-1 and Cntnap4. Cntnap4 is a pre-
synaptic membrane protein whereby global Cntnap4 loss differentially inhibits GABAergic output and augments
dopaminergic transmission, and can induce autism spectrum disorder (ASD)-like behaviors in mice. Remarkably,
ENU-induced Nell-1 haploinsufficient mice exhibit ASD-like behaviors similar to those seen in Cntnap4 mutant
mice. Meanwhile, inactivation of either Cntnap4 or Nell-1 in cranial neural crest cells (CNCCs) gives rise to
remarkably similar calvarial bone defects. Moreover, novel co-localization studies of Nell-1 and Cntnap4 in
mouse and human brains revealed broad neural tissue distribution and high levels of co-localized expression.
Consequently, this proposal hypothesizes that Nell-1 has dual roles in the brain and craniofacial bones (CB) via
a novel interaction between Nell-1 and Cntnap4, and that disruption of the Nell-1/Cntnap4 functional axis will not
only induce deficits in CB, but also interfere with neural transmission in the brain. This proposal advances three
specific aims to investigate the Nell-1/Cntnap4 functional axis in the CB and brain using two new floxed mouse
lines, Nell-1fl/fl and Cntnap4fl/fl. AIM 1 will first define the tissue distribution and expression of Nell-1 and Cntnap4
in both the CB and brain during normal development and growth in wild type (WT) mice. AIM 1 will then specify
the functional contributions of Nell-1 and Cntnap4 to the CB and brain using tissue-specific knockout (KO) Nell-
1Wnt1KO and Cntnap4Wnt1KO mice targeting CNCCs-derived CB and trigeminal ganglions (TG) by Wnt1-Cre, and
Nell-1PV-2AKO and Cntnap4PV-2AKO mice targeting parvalbumin positive (PV+) GABAergic neurons in the brain
and TG by PV-2A-Cre. The CB growth and behavioral changes in these KO mice will be correlated with
morphological changes in the examined bones, brain, and the craniofacial neuroskeletal interface where TG
sensory fibers innervate the CB. AIM 2 will decipher Nell-1's osteogenic property in the context of Cntnap4 during
the repair and regeneration of CB defects in Cntnap4Wnt1KO mice using Nell-1 protein. With Nell-1 serving as an
agonist of Wnt/β-catenin signaling, AIM 2 will determine how integrin β1, a Nell-1 binding partner, and glycogen
synthase kinase-3β (GSK3β), a crucial regulator of β-catenin phosphorylation, modulate Nell-1/Cntnap4
interaction-mediated Wnt/β-catenin signaling activation during CNCC osteogenesis. AIM 3 will investigate Nell-
1/Cntnap4 interaction on brain GABAergic transmission and ASD-like behaviors in Nell-1PV-2AKO and Cntnap4PV-
2AKO mice. AIM 3 will further assess Wnt/β-catenin signaling in the context of Nell-1/Cntnap4 interaction-
mediated GABA release, along with the possible additive or synergistic effects of GSK3β inhibitors with Nell-1 in
mouse neuronal cells. IMPACT: The ultimate goal is to reveal how the newly identified Nell-1/Cntnap4 interaction
may translate into developing Nell-1 as a novel therapeutic to treat human skeletal and neurological pathologies.
项目摘要
Nell-1在颅面骨骼发育中的成骨作用已被广泛研究。但尽管
由于Nell-1在大脑中的高表达,人们对Nell-1在神经系统中的功能缺乏了解
直到最近鉴定出Nell-1和Cntnap 4之间的配体-受体样相互作用。cntnap 4是一个前-
一种突触膜蛋白,Cntnap 4的整体缺失可不同程度地抑制GABA能输出并增强GABA能的表达
多巴胺能传递,并且可以在小鼠中诱导自闭症谱系障碍(ASD)样行为。值得注意的是,
ENU诱导的Nell-1单倍缺陷小鼠表现出与Cntnap 4突变体相似的ASD样行为
小鼠同时,在颅神经嵴细胞(CNCC)中Cntnap 4或Nell-1的失活引起
非常相似的颅骨缺损此外,Nell-1和Cntnap 4在细胞中的新的共定位研究,
小鼠和人脑显示出广泛的神经组织分布和高水平的共定位表达。
因此,该提议假设Nell-1在脑和颅面骨(CB)中具有双重作用,
Nell-1和Cntnap 4之间的一种新的相互作用,并且Nell-1/Cntnap 4功能轴的破坏不会
不仅诱导CB的缺陷,而且还干扰大脑中的神经传递。该提案提出了三个
本研究的目的是利用两种新的floxed小鼠研究Nell-1/Cntnap 4在CB和脑中的功能轴
AIM 1将首先确定Nell-1和Cntnap 4的组织分布和表达
在野生型(WT)小鼠的正常发育和生长过程中,CB和脑中均存在这种情况。AIM 1将指定
使用组织特异性敲除(KO)Nell-1和Cntnap 4对CB和脑的功能贡献,
通过Wnt 1-Cre靶向CNCC衍生的CB和三叉神经节(TG)的1 Wnt 1 KO和Cntnap 4 Wnt 1 KO小鼠,以及
靶向脑中小清蛋白阳性(PV+)GABA能神经元的Nell-1 PV-2AKO和Cntnap 4PV-2AKO小鼠
和TG通过PV-2A-Cre。这些KO小鼠中的CB生长和行为变化将与
形态学变化的检查骨,脑,颅面神经骨骼界面,其中TG
感觉纤维支配CB。AIM 2将解释Nell-1在Cntnap 4背景下的成骨特性,
使用Nell-1蛋白修复和再生Cntnap 4 Wnt 1 KO小鼠中的CB缺陷。Nell-1作为
作为Wnt/β-catenin信号传导的激动剂,AIM 2将决定整合素β1(Nell-1结合伴侣)和糖原
合成酶激酶3β(GSK 3 β)是β-catenin磷酸化的重要调节因子,调节Nell-1/Cntnap 4
CNCC成骨过程中相互作用介导的Wnt/β-catenin信号转导激活。AIM 3将调查内尔-
1/Cntnap 4相互作用对Nell-1 PV-2AKO和Cntnap 4PV-2AKO中脑GABA能传递和ASD样行为的影响
2只AKO小鼠。AIM 3将在Nell-1/Cntnap 4相互作用的背景下进一步评估Wnt/β-连环蛋白信号传导。
沿着GSK 3 β抑制剂与Nell-1的可能的相加或协同作用,
小鼠神经细胞影响:最终目标是揭示新发现的Nell-1/Cntnap 4相互作用是如何发生的。
可能转化为开发Nell-1作为治疗人类骨骼和神经病理学的新疗法。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Genetic and pharmacologic suppression of PPARγ enhances NELL-1-stimulated bone regeneration.
- DOI:10.1016/j.biomaterials.2022.121609
- 发表时间:2022-08
- 期刊:
- 影响因子:14
- 作者:
- 通讯作者:
Alternative splicing diversifies the skeletal muscle transcriptome during prolonged spaceflight.
替代剪接在长时间的太空飞行过程中使骨骼肌转录组多样化。
- DOI:10.1186/s13395-022-00294-9
- 发表时间:2022-05-31
- 期刊:
- 影响因子:4.9
- 作者:
- 通讯作者:
Bisphosphonate conjugation enhances the bone-specificity of NELL-1-based systemic therapy for spaceflight-induced bone loss in mice.
- DOI:10.1038/s41526-023-00319-7
- 发表时间:2023-09-18
- 期刊:
- 影响因子:5.1
- 作者:Ha, Pin;Kwak, Jin Hee;Zhang, Yulong;Shi, Jiayu;Tran, Luan;Liu, Timothy Pan;Pan, Hsin-Chuan;Lee, Samantha;Kim, Jong Kil;Chen, Eric;Shirazi-Fard, Yasaman;Stodieck, Louis S.;Lin, Andy;Zheng, Zhong;Dong, Stella Nuo;Zhang, Xinli;Wu, Benjamin M.;Ting, Kang;Soo, Chia
- 通讯作者:Soo, Chia
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chia Soo其他文献
Chia Soo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chia Soo', 18)}}的其他基金
Novel peptide for enhancing diabetic wound healing
促进糖尿病伤口愈合的新型肽
- 批准号:
10383864 - 财政年份:2021
- 资助金额:
$ 47.01万 - 项目类别:
Novel peptide for enhancing diabetic wound healing
促进糖尿病伤口愈合的新型肽
- 批准号:
10517746 - 财政年份:2021
- 资助金额:
$ 47.01万 - 项目类别:
Dual roles of Nell-1 in craniofacial bones and brain through interaction with Cntnap4
Nell-1 通过与 Cntnap4 相互作用在颅面骨和大脑中发挥双重作用
- 批准号:
10056723 - 财政年份:2020
- 资助金额:
$ 47.01万 - 项目类别:
Dual roles of Nell-1 in craniofacial bones and brain through interaction with Cntnap4
Nell-1 通过与 Cntnap4 相互作用在颅面骨和大脑中发挥双重作用
- 批准号:
10450876 - 财政年份:2020
- 资助金额:
$ 47.01万 - 项目类别:
Dual roles of Nell-1 in craniofacial bones and brain through interaction with Cntnap4
Nell-1 通过与 Cntnap4 相互作用在颅面骨和大脑中发挥双重作用
- 批准号:
10225640 - 财政年份:2020
- 资助金额:
$ 47.01万 - 项目类别:
Novel peptide-impregnated hydrogel as a wound healing device
新型肽浸渍水凝胶作为伤口愈合装置
- 批准号:
10689794 - 财政年份:2016
- 资助金额:
$ 47.01万 - 项目类别:
Novel peptide-coated suture for cleft lip and palate repair
用于唇裂和腭裂修复的新型肽涂层缝合线
- 批准号:
9244801 - 财政年份:2016
- 资助金额:
$ 47.01万 - 项目类别:
Novel peptide-impregnated hydrogel as a wound healing device
新型肽浸渍水凝胶作为伤口愈合装置
- 批准号:
10474270 - 财政年份:2016
- 资助金额:
$ 47.01万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 47.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 47.01万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 47.01万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 47.01万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 47.01万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 47.01万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 47.01万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 47.01万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 47.01万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 47.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)